Dan Jin is completing a PhD at the University of Alberta’s Department of Biomedical Engineering. She joined PBG BioPharma in July 2020 as a Research Scientist. Dan’s passion revolves around tapping into the potential of using cannabis inflorescences, leaves, stem, and roots for developing new natural health products & natural medicines and for bridging traditional medicine with modern science.
Dan has six years’ experience in cannabis testing and chemotaxonomy. She leads a cannabis classification project, a joint program between the Labs-Mart Inc., a third party testing lab, and the University of Alberta. Dan is responsible for conceiving the program, designing the experiments, and setting the direction for research. Throughout her career, Dan has developed quantitative methods for an extensive list of secondary metabolites in cannabis analytical chemistry methods, drafted commercials standard operating procedures, and validated methods in accordance with Health Canada protocols, including the quantification of cannabinoids, terpenoids, flavonoids, and sterols. She speaks at academic conferences and publishes articles in the fields of Analytical Chemistry, Natural Health Products, and Traditional Chinese Medicine.